Bristol Myers Squibb - News
WEBBristol Myers Squibb - News. Press Releases. Category: All Corporate/Financial News Philanthropy News R&D News Partnering News.
FDA approves Bristol Myers Squibb's schizophrenia drug
WEBSep 26, 2024 · The Food and Drug Administration approved Bristol Myers Squibb’s highly anticipated schizophrenia drug, the first novel type of treatment for the debilitating, chronic mental disorder in more ...
Bristol Myers Squibb - Bristol Myers Squibb Completes …
WEBMar 18, 2024 · PRINCETON, N.J.-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Karuna Therapeutics, Inc. (“Karuna”).
Bristol Myers Squibb - Bristol Myers Squibb Adds Premier ...
WEBDec 26, 2023 · Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio. Transaction Brings RayzeBio’s Differentiated Actinium-Based Radiopharmaceutical Platform, Including Rich Pipeline of Multiple Drug Development Programs, to Bristol Myers Squibb’s Leading Oncology Franchise. Lead Program, RYZ101, in …
Bristol Myers second-quarter results beat expectations, helped by …
WEBJul 26, 2024 · Drugmaker Bristol Myers Squibb posted better-than-expected second-quarter results, driven by growth from new products like anemia treatment Reblozyl and heart drug Camzyos as well as from its...
Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion
WEBDec 22, 2023 · Bristol Myers Squibb, the global pharmaceutical giant, said on Friday that it would acquire Karuna Therapeutics, which makes drugs to treat schizophrenia and Alzheimer’s, in an all-cash deal...
Bristol Myers Squibb Presents New Data from Two Trials …
WEBSep 27, 2024 · Bristol Myers Squibb: Pioneering Paths Forward in Immunology to Transform Patients’ Lives. ... corporatefinancial-news Contacts. Bristol Myers Squibb. Media Inquiries: [email protected].
Bristol-Myers Squibb to acquire Mirati in up to $5.8 billion deal
WEBOct 8, 2023 · Bristol-Myers Squibb on Sunday said it will acquire cancer drugmaker Mirati Therapeutics for up to $5.8 billion, diversifying its oncology business and adding drugs it hopes can help offset...
US FDA approves expanded use of Bristol Myers' cancer cell therapy
WEBMay 15, 2024 · The U.S. health regulator on Wednesday approved the expanded use of Bristol Myers Squibb's (BMY.N) cancer cell therapy Breyanzi for the treatment of adults with a type of blood cancer called ...
Pharmaceutical press releases & news - Bristol Myers Squibb
WEBExplore Bristol Myers Squibb's latest press releases to learn more about our company, our medicines and research innovation, our partnerships, our people, and our Foundation efforts as we work to support patients fighting serious disease.